Susan C. Adeniyi-Jones, MD

Abstinence scoring algorithms for treatment of neonatal opioid withdrawal syndrome (NOWS); Journal of Perinatology; (2024).

Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study; Journal of Perinatology; (2024).

Ondansetron to reduce neonatal opioid withdrawal severity a randomized clinical trial; Journal of Perinatology; (2023).

Algorithms for treatment of Neonatal Opioid Withdrawal Syndrome (NOWS) based on Modified and Abbreviated Finnegan Symptom Score; Unknown Source; (2023).

Polygenic risk scores and the need for pharmacotherapy in neonatal abstinence syndrome.; Pediatric research; (2022).

Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome; Clinical and Translational Science; (2021).

The Pharmacokinetics and Pharmacodynamics of Buprenorphine in Neonatal Abstinence Syndrome; Clinical Pharmacology & Therapeutics; (2018).

Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome.; The New England journal of medicine; (2017).